Cargando…

Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial

BACKGROUND: Patients with relapsed/refractory B-cell lymphomas have limited treatment options. GERSHWIN is an open-label, single-arm, phase Ib study of obinutuzumab monotherapy in Chinese patients with histologically documented CD20(+) relapsed/refractory chronic lymphocytic leukemia (CLL), diffuse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Yan, Song, Yuqin, Shen, Zhixiang, Du, Xin, Ji, Wei, Hsu, Wanling, Zhu, Jun, Shi, Yuankai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993131/ https://www.ncbi.nlm.nih.gov/pubmed/29843792 http://dx.doi.org/10.1186/s40880-018-0300-5

Ejemplares similares

Pharmacokinetics of obinutuzumab in Chinese patients with B‐cell lymphomas
por: Zhai, John, et al.
Publicado: (2017)

Efficacy and safety of obinutuzumab for the first-line treatment of follicular lymphoma: a subgroup analysis of Chinese patients enrolled in the phase III GALLIUM study
por: Hong, Xiaonan, et al.
Publicado: (2022)

Gershwin
por: Gauthier, André, 1918-2003
Publicado: (1977)

Gershwin for lovers
por: Gershwin, George, 1898-1937
Publicado: (1994)

The gershwin years
por: Jablonski, Edward
Publicado: (1958)

Gershwin concert
por: Gershwin, George, 1898-1937
Publicado: (1996)

Gershwin remembered /
por: Jablonski, Edward
Publicado: (1992)

Tschikowsky Gershwin /
por: Schmitt -Leonardy Wolfram

The Gershwin's Porgy and Bess
por: Gershwin, George, 1898-1937
Publicado: (1997)

The George Gershwin songbook.
por: Gershwin, George, 1898-1937
Publicado: (1990)

Kiri sings Gershwin
por: Gershwin, George, 1898-1937
Publicado: (1987)

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma
por: Grigg, Andrew, et al.
Publicado: (2017)

Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
por: Younes, Anas, et al.
Publicado: (2022)

Gershwin,Copland, Bar ber
por: Gershwin, George, 1898-1937
Publicado: (1989)

Meet George Gershwin at the piano
por: Gershwin, George, 1898-1937
Publicado: (1938)

Copland, Gershwin, Bernstein, Stravinsky
Publicado: (1993)

The George and Ira Gershwin songbook
por: Gershwin, George, 1898-1937
Publicado: (1985)

The George Gershwin & Cole Porter songbook
Publicado: (1990)

The great jazz vocalists sing the Gershwin songbook
por: Gershwin, George, 1898-1937
Publicado: (1992)

Joplin & Gershwin Cuarteto de Saxofones de México/
por: Pérez Piton Abel

Impact of obinutuzumab alone and in combination for follicular lymphoma
por: Sarraf Yazdy, Maryam, et al.
Publicado: (2017)

The clinical development of obinutuzumab for the treatment of follicular lymphoma
por: Ma, Barbara, et al.
Publicado: (2017)

Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab‐refractory follicular lymphoma patients in the GADOLIN phase III study
por: Gibiansky, Ekaterina, et al.
Publicado: (2019)

Buddy De Franco and Oscar Peterson play George Gershwin
por: Gershwin, George, 1898-1937
Publicado: (1998)

Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL
por: Agrawal, Rohitashva, et al.
Publicado: (2020)

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
por: Kutsch, Nadine, et al.
Publicado: (2022)

P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF THE ROSEWOOD STUDY
por: Trotman, Judith, et al.
Publicado: (2023)

Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
por: Kutsch, Nadine, et al.
Publicado: (2022)

Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia
por: Sharman, Jeff P., et al.
Publicado: (2022)

Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma
por: Ueda, Yayoi, et al.
Publicado: (2022)

Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma
por: Spencer, Scott J, et al.
Publicado: (2021)

Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL
por: Mascolo, Annamaria, et al.
Publicado: (2023)

P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CITADEL-102)
por: Hamadani, M., et al.
Publicado: (2022)

Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model
por: Decaup, E, et al.
Publicado: (2013)

Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first‐line immunochemotherapy
por: Jamois, Candice, et al.
Publicado: (2019)

Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma
por: Claustre, Gwladys, et al.
Publicado: (2022)

Disseminated Enteroviral Infection Associated with Obinutuzumab
por: Dendle, Claire, et al.
Publicado: (2015)

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
por: Cheadle, E J, et al.
Publicado: (2017)

PB2273: EFFICACY OF OBINUTUZUMAB - BASED REGIMENS IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: A RETROSPECTIVE OBSERVATIONAL SINGLE-CENTER STUDY
por: Ridova, Nevenka, et al.
Publicado: (2023)

Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial
por: Herold, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_crkjks7pbfn9g3fjmllanr4ht1